CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

AHA Advisory Recommends Healthy Eating, Not Just Variety

Published: Fri, 17 Aug 2018 08:09:54 EDT
The advice to 'eat a variety of foods' is outdated because studies show a more varied diet often included more unhealthy foods and was not linked with a healthier weight, an AHA advisory reports.
Medscape Medical News

Study Supports Newest Indication for IL6R Blockade in Giant Cell Arteritis

Published: Fri, 17 Aug 2018 07:45:03 EDT
New research confirms the association of a common variant in the gene that encodes the receptor for IL-6 with reduced risk for aortic aneurysm and supports the newest indication for IL6R blockade, giant cell arteritis.
Medscape Medical News
Displaying results 19-20 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

MD Anderson, Accelerator bake up Magnolia, an NYC biotech in neuroprotection, with $31M series A

Published: Fri, 10 Aug 2018 18:04:50 +0000
MD Anderson Cancer Center and Accelerator Life Science Partners have co-founded a new company, Magnolia Neurosciences, to develop a new class of targeted neuroprotective drugs discovered by the cancer center’s researchers.

UC Berkeley backs oral gene therapy company targeting the gut in $1.5M seed round

Published: Fri, 10 Aug 2018 13:12:33 +0000
A UC Berkeley-backed preclinical company, DNAlite Therapeutics, has gathered $1.5 million in seed money to pursue oral gene therapies that can slip through the mucus barrier that typically blocks access to the gastrointestinal tract.

Astellas absorbs U.K. ocular gene therapy player Quethera

Published: Fri, 10 Aug 2018 12:09:13 +0000
Japan’s Astellas Pharma has delved deeper into the gene therapy sector, picking up U.K. specialist Quethera for around $109 million.
Displaying results 22-24 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top